Rehmann Capital Advisory Group’s Loxo Oncology, Inc LOXO Stock Holding History

Rehmann Capital Advisory Group’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-18	Closed	-$2.52K	–	2180
2018 Q4	$2.52K	Buy	+18	New	+$2.73K	﹤0.01%	1405

Other funds holding LOXO

IUHSA

Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

Rehmann Capital Advisory Group's LOXO Position: Q1 2019 in Review

Rehmann Capital Advisory Group sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 18 shares — an estimated $2.52K sold.

Rehmann Capital Advisory Group first reported a position in LOXO in Q4 2018 and held it in 1 quarter. The position peaked at $2.52K in Q4 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

Rehmann Capital Advisory Group reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
Rehmann Capital Advisory Group sold 18 Loxo Oncology, Inc shares in Q1 2019, an estimated $2.52K.
Rehmann Capital Advisory Group first reported a position in Loxo Oncology, Inc in Q4 2018 and held it in 1 quarter.
Rehmann Capital Advisory Group's Loxo Oncology, Inc position peaked at $2.52K in Q4 2018.
1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Rehmann Capital Advisory Group's 13F filing for Q1 2019, filed 22 May 2019.